It’s not always easy to spot Alabama on a map, but it’s hard to overlook the impact Alabama’s bioscience sector has had on our state’s reputation, economic development, and the lives of everyone it’s touched.
Beyond cutting-edge research and technology, one of the most notable achievements of the bioscience sector is the high level of employment that it has created. Nearly 14,000 Alabamians are employed in life science or biotechnology jobs, with average annual income topping $66,000. The economic engine that is the University of Alabama at Birmingham (UAB) alone is responsible for an estimated 53,000 jobs — almost 10 percent of the total in the Birmingham-Hoover metropolitan area.
Pharmaceutical and medical device manufacturing is expanding across the state. Oxford Pharmaceuticals is opening a $29 million manufacturing facility in Birmingham that will eventually employ 200 people. In Opelika, medical device company Baxter is investing $300 million expansion expected to add 200 new jobs.
At the center of considerable activity is Huntsville’s Cummings Research Park (CRP), the second largest research and technology park in the U.S. Home to a mix of Fortune 500 companies and homegrown innovators, along with nearly 30,000 employees, CRP contributes to the success of many high-tech enterprises, U.S. defense and aerospace agencies, and higher-education institutions.
- 800+ bioscience companies
- 54 medical device companies
- NIH Funding totaled $280 million in 2015
- 14,000 employed in bioscience
- 623 bioscience patents awarded, 2009-2013
- Southern Research discovered 7 FDA-approved anticancer drugs
- Alabama Drug Discovery Alliance has 18 potential drugs in pipeline
- Cummings Research Park is the 2nd largest research and technology park in the U.S.
- Multiple teaching hospitals across the state
- AIMTech (Alliance for Innovative Medical Technology)
- Alabama Drug Discovery Alliance (ADDA)
- Agenta Biotechnologies
- Blondin Bioscience
- CFD Research Corp.
- Conversant Bio
- Dilyx Biotechnologies (Soluble Therapeutics)
- Discovery BioMed
- Evonik Industries
- Gem Pharmaceuticals
- H2 Pharma
- HudsonAlpha Institute for Biotechnology
- Kowa Pharmaceuticals
- Nektar Therapeutics
- Midlothian Labs
- Oxford Pharmaceuticals
- Par Pharmaceuticals
- Pharmavite (Nature’s Made)
- Serina Therapeutics
- Soluble Therapeutics
- Southern Research
- USA Mitchell Cancer Center
- US Diagnostics
- Vivo Biosciences